Xiuzheng Pharmaceutical Group Aims For A-Share Listing
This article was originally published in PharmAsia News
Executive Summary
Xiuzheng Pharmaceutical Group plans to go for A-share listing at the end of this year or early 2009, according to the company's president. As a TCM enterprise, Xiuzheng ranks among China's top 10 pharmaceutical corporations with its revenue of 5.7 billion yuan in 2007. The company will begin constructing its biomedical industry park with 1 billion yuan. With the biomedical industry its second largest core business, it aims to create value in the capital market for investors. An analyst notes that going public is inevitable for Xiuzheng, but whether it is the right move at a time when China's stock market is slowing down remains to be seen. (Click here for more - Chinese Language)